This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Six Bullish Stocks Will Pay You High Dividends

LLY Chart LLY data by YCharts

Eli Lilly (LLY - Get Report)

Background: Eli Lilly discovers, develops, manufactures and sells pharmaceutical products worldwide. The company was founded in 1876 and is headquartered in Indianapolis, Ind. The stock trades an average of 8.4 million shares per day with a marketcap of $60 billion.

52-Week Range: $35.46 to $53.99

Book Value: $12.33

Price to Book: 4.2

Earnings Payout Percentage: 54%

In the last month, the stock has really moved higher with a 10.8% increase. Investors are receiving $1.96 in dividends for a yield of 3.65%. The story gets even better looking at the monster 33% rise in share price over the last 52 weeks. Analysts are calling for a price target of $50.46.

This isn't the first time I brought up Eli Lilly. At the end of August, I wrote about the company in Six Bullish Stocks That Pay High Dividends . I liked the company then and I continue to like it now. I would not chase it though and allowing for a pullback before entry may be prudent.

TheStreet's Jim Cramer writes about Eli Lilly in Watch out for the Tightrope .

LLY Dividend Chart LLY Dividend data by YCharts

It doesn't take Tom DeMark at to figure out Lilly is running up the chart fast. The moving averages are rock-solid bullish and money is pouring into this equity. One note of caution, once the sugar high of the Affordable Care Act wears off, the health industry may face serious headwinds. Investors should obviously keep a little closer eye on the makeup of Washington next year.

The last reported short interest is paltry and without reason to consider it a meaningful influence at only 1.7% of the average trading float.

3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
BMY $65.86 0.09%
GIS $56.06 -0.57%
GE $26.90 0.39%
JPM $62.96 0.58%
LLY $71.26 -0.45%


DOW 18,134.66 +54.52 0.30%
S&P 500 2,121.30 +3.61 0.17%
NASDAQ 5,103.0280 +10.9430 0.21%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs